ASCO 2022 Updates on the Phase II DANTE Trial: Surgical & Pathological Outcome in Pts Receiving Perioperative Atezo + FLOT vs. FLOT Alone for Resectable GEJ

84 views
August 31, 2022
Comments 0
Login to view comments. Click here to Login